Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: memo - Magazine of European Medical Oncology 1/2022

01.02.2022 | editorial

New frontiers in chronic lymphocytic leukemia on the way to curing the disease

verfasst von: Univ.-Prof. Dr. Philipp Staber

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten
share
TEILEN

Excerpt

Chronic lymphocytic leukemia (CLL) is the most common leukemia in the western world and is considered to be incurable. In the last 10 years, novel therapeutics, like B cell receptor blockers and the bcl‑2 inhibitor venetoclax have transformed the prognosis for CLL patients [ 1]. In this issue of the Magazine of European Medical Oncology (MEMO), we discuss the perspectives of novel strategies to actually cure CLL patients. …
Literatur
Metadaten
Titel
New frontiers in chronic lymphocytic leukemia on the way to curing the disease
verfasst von
Univ.-Prof. Dr. Philipp Staber
Publikationsdatum
01.02.2022
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 1/2022
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-022-00795-9